In a murine model of CML driven by BCR-ABL expression in HSCs, they demonstrated that CML is induced and sustained by high IL-6 levels produced by BCR-ABL-expressing cells (107). Here, IL6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.